Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04377360 · ClinicalTrials.gov registry record · NA
Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin & Superficial Soft Tissue Tumors
A NA study, sponsored by Alpha Tau Medical.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04377360 is a NA study that has completed, run by Alpha Tau Medical. The registered enrollment target is 10 participants.
The verdict
NCT04377360, a NA study, has completed, sponsored by Alpha Tau Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
This is a single-institution pilot feasibility trial in which 10 subjects will be enrolled. The primary objectives are is to explore the feasibility of delivering radiotherapy for malignant skin and superficial soft tissue tumors using DaRT (Alpha Tau Medical, Tel Aviv, Israel), a form of interstitial brachytherapy which uses a novel radioisotope delivery system, as well as to determine the frequency and severity of acute adverse events. Secondary objectives will include assessments of radiotherapy-related adverse events, tumor response, radiation safety, stability of device placement, and associations with quality of life.
Interventions
- RADIATION Diffusing Alpha-emitter Radiation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2020-01-06 |
| Est. Completion | 2022-03-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04377360
The ClinicalTrials.gov registry entry for NCT04377360 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alpha Tau Medical, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Diffusing Alpha-emitter Radiation Therapy is the first listed.
NCT04377360 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04377360 about?
NCT04377360 is a clinical study titled "Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin & Superficial Soft Tissue Tumors". This is a single-institution pilot feasibility trial in which 10 subjects will be enrolled. The primary objectives are is to explore the feasibility of delivering radiotherapy for malignant skin and superficial soft tissue tumors using DaRT (Alpha Tau Medical, Tel Aviv, Israel), a form of interstiti...
What is the current status of trial NCT04377360?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2020-01-06. Estimated completion is 2022-03-28.
What interventions are being tested in trial NCT04377360?
The interventions under investigation include: Diffusing Alpha-emitter Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT04377360?
This trial is sponsored by Alpha Tau Medical, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.